Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Capecitabine|Triple Negative Breast Cancer
Sponsor: Xijing Hospital
Collaborators: Roche Pharma AG